Life Sciences PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer AIT News Desk Jan 12, 2021 Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit at Pfizer, to join Vedanta’s Scientific…